Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
US5919453A · kind A · utility
27Cited by
1References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 5, 1994 |
| Grant date | Jul 6, 1999 |
| Priority date | — |
| Expiry date | Dec 5, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A monoclonal antibody directed against the human interferon type I receptor (IFN-R), which recognizes the extracellular domain of the human IFN-R and has neutralizing capacity against the biological properties of human type I-IFN. Diagnostic applications for the monoclonal antibody also are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.